N-(5-Bromopyridin-2-yl)-4-phenoxybutanamide

ID: ALA4546726

PubChem CID: 84376194

Max Phase: Preclinical

Molecular Formula: C15H15BrN2O2

Molecular Weight: 335.20

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(CCCOc1ccccc1)Nc1ccc(Br)cn1

Standard InChI:  InChI=1S/C15H15BrN2O2/c16-12-8-9-14(17-11-12)18-15(19)7-4-10-20-13-5-2-1-3-6-13/h1-3,5-6,8-9,11H,4,7,10H2,(H,17,18,19)

Standard InChI Key:  VSMNGDLLMZDBMO-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 20 21  0  0  0  0  0  0  0  0999 V2000
   31.8897   -4.3005    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.8885   -5.1201    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.5966   -5.5290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.3062   -5.1196    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.3034   -4.2969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.5948   -3.8917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.1819   -3.8921    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.4743   -4.3009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7665   -3.8924    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.0588   -4.3012    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.3510   -3.8928    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.6434   -4.3016    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.3508   -3.0756    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   26.9356   -3.8931    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.9395   -3.0760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.2325   -2.6677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.5239   -3.0765    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.5268   -3.8979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.2343   -4.3026    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.8156   -2.6690    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  1  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 17 20  1  0
M  END

Alternative Forms

Associated Targets(Human)

HEK293 (82097 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

tat Human immunodeficiency virus type 1 Tat protein (1183 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 335.20Molecular Weight (Monoisotopic): 334.0317AlogP: 3.64#Rotatable Bonds: 6
Polar Surface Area: 51.22Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 12.09CX Basic pKa: 2.29CX LogP: 3.40CX LogD: 3.40
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.82Np Likeness Score: -1.66

References

1. Nguyen W, Jacobson J, Jarman KE, Jousset Sabroux H, Harty L, McMahon J, Lewin SR, Purcell DF, Sleebs BE..  (2019)  Identification of 5-Substituted 2-Acylaminothiazoles That Activate Tat-Mediated Transcription in HIV-1 Latency Models.,  62  (10): [PMID:30973727] [10.1021/acs.jmedchem.9b00462]

Source